Addictions and mental health

In programme

14 sessions 68 presentations View the programme

About

This track is co-produced by the Society for the Study of Addiction (SSA).

Addiction, mental health and co-occurring mental illness in different populations.
Addiction and trauma.
COVID-19 implications for addictions and mental health.
Strategies for prevention of mental health problems and suicide among people with addictions.
Addiction and neurodiversity.

Sessions

Wednesday, 23 November

10:50

Substance use, mental health and mental well-being: observations, interventions and recovery promotion

Networking zone 3 (N3)

Short communication session

Substance-induced psychosis: register-linkage research in Nordic countries

Knowledge market 2 (K2)

Structured session

15:00

Substance use and mental health disorders in Europe: prevalence, models of care, and implementation in a challenging COVID-19 context

Knowledge market 2 (K2)

Structured session

Understanding relationships between substance use, mental health and mental illness: Session 1

Networking zone 2 (N2)

e-poster guided tour

16:50

Addiction and comorbidity over the lifespan: mechanisms and interventions

Central square 2 (C2)

Structured session

Impact and lessons learned in implementing and sustaining Needs-Based Planning models for substance use and mental health services and systems

Knowledge market 2 (K2)

Structured session

Thursday, 24 November

10:50

Substance use and trauma

Knowledge market 2 (K2)

Oral presentation session

13:20

Childhood risk factors in substance use and mental health

Knowledge market 2 (K2)

Oral presentation session

15:00

Substance use and mental health during COVID-19

Knowledge market 2 (K2)

Oral presentation session

Understanding relationships between substance use, mental health and mental illness: Session 2

Networking zone 2 (N2)

e-poster guided tour

16:50

Substance use, suicide and self-harm: epidemiology and prevention

Structured session

Friday, 25 November

10:50

Associations of alcohol and substance use with mental health

Knowledge market 2 (K2)

Structured session

13:20

Stress and Addiction: Updates on the Chicken or Egg question

Central square 4 (C4)

Structured session

Substance use, mental health risk and suicide

Knowledge market 2 (K2)

Oral presentation session

Presentations

Wednesday, 23 November

10:50

Short communication

The temporal association between frequency of methamphetamine use, depression, and anxiety in a community-recruited cohort of methamphetamine smokers

Networking zone 3 (N3)

Short communication

Effectiveness of mental health warnings on tobacco packaging in people with and without common mental health conditions: an online randomised experiment

Networking zone 3 (N3)

Katherine Sawyer

Short communication

A realist evaluation of greenspace programmes for improving mental health and supporting people with problem substance use

Networking zone 3 (N3)

Wendy Masterton

Oral presentation

1. Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016

Knowledge market 2 (K2)

Eline Borger Rognli

Short communication

Association between cannabis use and mental health disorders in adolescents in Catalonia: results of a cohort study

Networking zone 3 (N3)

Regina Muñoz-Galán

Oral presentation

2. Characteristics of incident substance-induced psychosis compared to incident first episode psychosis. A nationwide register-linkage study

Knowledge market 2 (K2)

Short communication

Physical activity during treatment for substance use disorder: What a systematic review tells us

Networking zone 3 (N3)

Florence Piché

Oral presentation

3. Relapse rate of substance-induced psychosis and associated risk factors. A nationwide registerlinkage study

Knowledge market 2 (K2)

Short communication

Drug use, anxiety and depression among people living in prison in Belgium

Networking zone 3 (N3)

Oral presentation

4. Substance-induced psychosis and later schizophrenia or bipolar disorder: transition rates and the role of infections

Knowledge market 2 (K2)

Jørgen G. Bramness

Oral presentation

5. Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychosis. A nationwide register-linkage study

Knowledge market 2 (K2)

Jeyaniroshan Jeyapalan

Short communication

Mental Health and Addiction Prevention for former refugees: We do it together

Networking zone 3 (N3)

Jannet De Jonge

15:00

A systematic review and meta-analyses of longitudinal studies on mood and anxiety symptoms following prescription opioid use.

Networking zone 2 (N2)

Vicarious trauma among nurses working in addiction services and the role of leadership: a European mixed methods study

Networking zone 2 (N2)

K. Nicki Annunziata

Cognitive screening for long term substance use outcome in a cohort of patients with polysubstance use disorder

Networking zone 2 (N2)

Anhedonia during recovery of polysubstance use

Networking zone 2 (N2)

Aleksander Erga

COVID-19 pandemic induces severe impact on substances administration and on aspects of psychosocial life of patients under methadone and buprenorphine maintenance treatment

Networking zone 2 (N2)

Vasilios Stavropoulos

Oral presentation

1. What do we mean by psychiatric comorbidity or dual disorders?

Knowledge market 2 (K2)

Bridging the Gap in Violence Prevention and Mental Health Support through Culturally Relevant Community-Led Initiatives.

Networking zone 2 (N2)

Oral presentation

2. Impact of Covid19 on mental health and drug use: main findings from the EMCDDA trendspotter study

Knowledge market 2 (K2)

Franca Beccaria

Oral presentation

3. Psychiatric comorbidity in the European countries: prevalence and models of care

Knowledge market 2 (K2)

Francina Fonseca

Oral presentation

4. The dual diagnosis inpatient and outpatient treatment program in Ljubljana: practical implementatio

Knowledge market 2 (K2)

Nusa Segrec, Andrej Kastelic

Discussion: Substance use and mental health disorders in Europe

Knowledge market 2 (K2)

Gabriele Fischer

16:50

Oral presentation

1. Implementation of a substance use NBP model in a Northern Region of Ontario- results and lessons learned

Knowledge market 2 (K2)

Stephanie Paquette

Oral presentation

1. First findings of an RCT on treatment of PTSD in addiction: simultaneous or sequential treatment with EMDR, Prolonged Exposure, Imaginary Rescripting

Central square 2 (C2)

Oral presentation

3. Development and pilot testing an integrated mental health and substance use Needs-based Planning model: Lessons learned for local planning and model refinements

Knowledge market 2 (K2)

Oral presentation

2. Older adults and alcohol use: negative affect, resilience, and alcohol use as interacting factors

Central square 2 (C2)

Yannick van Gils

Oral presentation

5. Focus on implementation processes, impacts to date and pros and cons of the sustainability of the Australian Mental Health model

Knowledge market 2 (K2)

Oral presentation

3. Effectiveness of a digital alcohol moderation intervention as an add-on to depression treatment for young adults: findings of a pragmatic randomized controlled trial

Central square 2 (C2)

Maria J.E. Schouten

Oral presentation

4. Illegal substance use during pregnancy: what do we know about risks and detoxification?

Central square 2 (C2)

Cleo L. Crunelle

Oral presentation

2. Impact and lessons learned in the implementation of a NBP model across the province of Quebec, Canada

Knowledge market 2 (K2)

Strategic approach to service prioritization and resource allocation

Knowledge market 2 (K2)

Thursday, 24 November

10:50

Oral presentation

The association between moral injury and cannabis use disorder among Israeli combat veterans: current state of knowledge and future directions

Knowledge market 2 (K2)

Daniel Feingold

Oral presentation

Alcohol and drug use among trauma patients with injuries of violence– results from the IDART study

Knowledge market 2 (K2)

Benedicte Jørgenrud

Oral presentation

addictive disorders and post-traumatic stress disorders

Knowledge market 2 (K2)

Léa Montagnier

Oral presentation

A novel trauma-focused psychological therapy for co-occurring substance use and PTSD among adolescents

Knowledge market 2 (K2)

13:20

Oral presentation

Longitudinal patterns of problematic cannabis use in adolescence and their association with childhood psychological risk factors

Knowledge market 2 (K2)

Oral presentation

Childhood maltreatment and alcohol problems in young adulthood: coping style as a mediator and potential intervention target.

Knowledge market 2 (K2)

Lucinda Grummitt

Oral presentation

Exploring the link between childhood maltreatment and substance use disorder using a prospective, genetically informative and experimental approach

Knowledge market 2 (K2)

Andrea Johansson Capusan

Oral presentation

The Role of Adverse Childhood Experiences (ACEs) on People in Opiate Agonist Treatment: The importance of feeling unloved

Knowledge market 2 (K2)

15:00

Oral presentation

The role of place-making dynamics in recovery from co-occurring disorders: An in-depth ethnographic study

Knowledge market 2 (K2)

Clara De Ruysscher

Program 'Eu e os Outros': Adaptation to the university context

Networking zone 2 (N2)

Mariana Montalvão

Khat and neurobehavioral functions: a systematic review

Networking zone 2 (N2)

Manuel Jesús Ruiz Muñoz

Group Intervention for Parents of People With Psychotic and Substance Use Disorders: A Qualitative Evaluation of appropriateness

Networking zone 2 (N2)

Karine Gaudreault

How Attention Deficit Hyperactivity Disorder and Substance Use Disorder influence each other: A non-systematic literature review

Networking zone 2 (N2)

Catarina Oliveira

Smoking-related health inequalities, tobacco smoking and substance use disorder.

Networking zone 2 (N2)

Mireia Graell Gabriel

Substance-Related Problems in Adolescents with ADHD-Diagnoses: The Importance of Self-Reported Conduct Problems

Networking zone 2 (N2)

Ove Heradstveit

Oral presentation

Changes in mental health among drug users during Covid-19. Evidence from a repeated cross-sectional survey in Belgium

Knowledge market 2 (K2)

Oral presentation

Online peer support for concurring mental health and addiction problems during the Covid19 pandemic: feeling of group inclusion and perceived effectiveness.

Knowledge market 2 (K2)

Raffaella Milani

The Clinical Course of Comorbid Substance Use Disorder and Attention Deficit/Hyperactivity Disorder: Protocol and Clinical Characteristics of the INCAS Study

Networking zone 2 (N2)

16:50

Oral presentation

Suicide and self-harm during COVID-19 and beyond.

Oral presentation

Adolescent substance use, self-harm and suicide: Findings from the Northern Finland Birth Cohort 1986.

Oral presentation

Restricting access to means: Public health approaches to reduce drug- and alcohol-related self-harm.

Friday, 25 November

10:50

Oral presentation

1. Socioeconomic status, alcohol use and the mediating role of social support and neighbourhood disadvantage among individuals meeting criteria for a mental health problem: a cross-sectional study

Knowledge market 2 (K2)

Jo-Anne Puddephatt

Oral presentation

2. The association between mental health and alcohol use in racial and ethnic groups: A secondary data analysis across studies

Knowledge market 2 (K2)

Oral presentation

3. Association of psychological distress with smoking cessation, duration of smoking abstinence and use of other nicotine-containing products: A cross-sectional population survey in Great Britain

Knowledge market 2 (K2)

Oral presentation

4. Can we make cannabis safer? An experimental study of four CBD: THC rations in healthy volunteers

Knowledge market 2 (K2)

Commonalities across the research on different substances

Knowledge market 2 (K2)

13:20

Oral presentation

Hazardous, harmful and dependent alcohol use in Crisis Resolution Team patients: relationship with death or service recontact after a suicidal crisis.

Knowledge market 2 (K2)

Oral presentation

Comparing characteristics of suicide to non-suicide drug poisoning, by sex, in Ireland.

Knowledge market 2 (K2)

Oral presentation

Characteristics associated with suicide among people who use drugs in Ireland 2015 to 2017: a repeated cross-sectional study

Knowledge market 2 (K2)

Oral presentation

Implementation of a community-based psychiatric intervention among people who inject drugs in the City of Haiphong, Vietnam: the DRIVE-Mind project

Knowledge market 2 (K2)

Oral presentation

The impact of detoxification on suicidal behaviour among heroin users: longitudinal data from South Africa

Knowledge market 2 (K2)

Oral presentation

1. Cue-induced cocaine craving enhances psychosocial stress and vice versa in chronic cocaine users

Central square 4 (C4)

Oral presentation

2. The endocannabinoid system and drug addiction: basal and stress-related endocannabinoid plasma levels in chronic cocaine users and prescription opioid users

Central square 4 (C4)

Oral presentation

3. The endocannabinoid system as a potential buffer against the development of a substance use disorder following childhood trauma exposure

Central square 4 (C4)

Oral presentation

4. Understanding the mechanisms that link childhood stress with risk of addiction

Central square 4 (C4)

Oral presentation

5. Is opioid liking driven by relief or reward? Evidence from clinical and experimental studies of acute stress

Central square 4 (C4)

Isabell M. Meier

View all tracks Next track